Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioanalysis|December 23, 2014
Quantifying vemurafenib in dried blood spots using high-performance LC-MS/MSCynthia M Nijenhuis, Hilde Rosing, Jan H M Schellens, et al.
British Journal of Clinical Pharmacology|August 6, 2011
Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature reviewCynthia M Nijenhuis, Peter G J ter Horst, Lolkje T W de Jong-van den Berg, et al.
Pharmacoepidemiology and Drug Safety|August 4, 2010
Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?Janneke Jentink, Marian K Bakker, Cynthia M Nijenhuis, et al.
Clinical Pharmacokinetics|February 26, 2014
Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targetsHuixin Yu, Neeltje Steeghs, Cynthia M Nijenhuis, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 22, 2016
Metabolite profiling of 14C-omacetaxine mepesuccinate in plasma and excreta of cancer patientsCynthia M Nijenhuis, Luc Lucas, Hilde Rosing, et al.
British Journal of Clinical Pharmacology|August 19, 2011
Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypothesesCynthia M Nijenhuis, Peter G J ter Horst, Nienke van Rein, et al.
Investigational New Drugs|March 29, 2016
Metabolite profiling of the multiple tyrosine kinase inhibitor lenvatinib: a cross-species comparisonAnne-Charlotte Dubbelman, Cynthia M Nijenhuis, Robert S Jansen, et al.
Journal of Clinical Pharmacology|February 27, 2016
The Use of Dried Blood Spots for Pharmacokinetic Monitoring of Vemurafenib Treatment in Melanoma PatientsCynthia M Nijenhuis, Alwin D R Huitema, Serena Marchetti, et al.
Investigational New Drugs|May 26, 2016
Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumorsCynthia M Nijenhuis, Edward Hellriegel, Jos H Beijnen, et al.
The British Journal of Surgery|June 6, 2025
Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trialLiselotte Tas, Marie B Weitemeyer, Maartje W Rohaan, et al.
Pageof 2